Resolving cancer’s complexity

How can it impact the world and/or benefit society?

Primarily, by bringing new medicines to patients there is an incredible opportunity to improve and save people’s lives. That’s why we come to work every day.

We have an extraordinarily talented team that is working every day on the cutting edge of science. Our platform was borne out of the Sanger, an institute that is world-renowned for mapping one-third of the human genome, and from the ground-breaking work of Dr Mathew Garnett and his team that co-discovered the BRAF mutation in cancer. Mosaic will continue this great history, striving at the forefront of experimental biology and computational science. With our learning platform we hope to inspire new science and technologies to improve cancer research and development around the world.

What is the market opportunity?

By taking an unbiased, agnostic and prospective approach, the opportunity to impact patients and grow our business is seemingly limitless, because Mosaic is looking at the entire spectrum of potential targets and possible single or combination drug candidates. Our discovery platform is alive and dynamic, so as we gain more experience and grow our data banks, our machine learning capabilities will increase exponentially. There is no ceiling to the number of medicines we can discover and develop.